Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077713044> ?p ?o ?g. }
- W2077713044 endingPage "2905" @default.
- W2077713044 startingPage "2898" @default.
- W2077713044 abstract ": To date, the standard treatment for patients who have carcinoma of unknown primary site has not been established.: In this randomized Phase II study, 66 previously untreated patients (33 patients per arm) with carcinomas of unknown primary site received cisplatin (35 mg/m2) and gemcitabine (1000 mg/m2) with either paclitaxel (70 mg/m2) or vinorelbine (25 mg/m2), and all drugs were administered intravenously on Days 1 and 8 of a 21-day cycle. Twenty-nine patients (44%) presented with > or =2 involved sites. The pathologic diagnosis was mainly adenocarcinoma (48 patients; 72.7%) and squamous carcinoma (7 patients; 10.6%).: In the first arm, 16 patients (48.5%) experienced an objective response, and 9 patients (27.2%) had disease stabilization. In the vinorelbine-containing arm, 14 patients (42.3%) experienced an objective response, and 8 patients (24.2%) had disease stabilization. The median response duration and the median time to progression were similar in both treatment arms; the median overall survival was 9.6 months (95% confidence interval, 7.11-12.09 months) for patients who received the cisplatin/gemcitabine/paclitaxel regimen and 13.6 months (95% confidence interval, 6.61-20.59 months) for patients who received the vinorelbine combination. Grade 3 and 4 toxicities were more frequent in the paclitaxel-containing arm.: Both combinations satisfied the 2-step design, demonstrating antitumor activity without relevant differences in response rates or response duration; however, the vinorelbine-containing regimen yielded superior results both in terms of overall survival (13.6 months vs 9.6 months) and in terms of treatment tolerability. Therefore, according to a pick the winner attitude, the combination of cisplatin/gemcitabine/vinorelbine may be considered in the design of future randomized, Phase III trials for patients with carcinomas of unknown primary site." @default.
- W2077713044 created "2016-06-24" @default.
- W2077713044 creator A5044926112 @default.
- W2077713044 creator A5048720703 @default.
- W2077713044 creator A5056559714 @default.
- W2077713044 creator A5058495826 @default.
- W2077713044 creator A5073106835 @default.
- W2077713044 creator A5083011981 @default.
- W2077713044 creator A5089288192 @default.
- W2077713044 creator A5090055323 @default.
- W2077713044 creator A5090509109 @default.
- W2077713044 creator A5090814125 @default.
- W2077713044 date "2006-01-01" @default.
- W2077713044 modified "2023-10-16" @default.
- W2077713044 title "Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site" @default.
- W2077713044 cites W1531882167 @default.
- W2077713044 cites W1913120928 @default.
- W2077713044 cites W1964619160 @default.
- W2077713044 cites W1964998139 @default.
- W2077713044 cites W1968626722 @default.
- W2077713044 cites W1972295448 @default.
- W2077713044 cites W1983333559 @default.
- W2077713044 cites W1998397384 @default.
- W2077713044 cites W2011137929 @default.
- W2077713044 cites W2017129426 @default.
- W2077713044 cites W2023234202 @default.
- W2077713044 cites W2029409133 @default.
- W2077713044 cites W2035106376 @default.
- W2077713044 cites W2059529166 @default.
- W2077713044 cites W2066135829 @default.
- W2077713044 cites W2071228730 @default.
- W2077713044 cites W2076177319 @default.
- W2077713044 cites W2088251977 @default.
- W2077713044 cites W2094767885 @default.
- W2077713044 cites W2109844575 @default.
- W2077713044 cites W2112126084 @default.
- W2077713044 cites W2127738265 @default.
- W2077713044 cites W2147627498 @default.
- W2077713044 cites W2148094326 @default.
- W2077713044 cites W2163823979 @default.
- W2077713044 cites W2166550667 @default.
- W2077713044 cites W2167805334 @default.
- W2077713044 cites W2186962695 @default.
- W2077713044 cites W2224135239 @default.
- W2077713044 cites W2275567662 @default.
- W2077713044 cites W2282791948 @default.
- W2077713044 cites W2285683947 @default.
- W2077713044 cites W2511536500 @default.
- W2077713044 cites W4293241248 @default.
- W2077713044 doi "https://doi.org/10.1002/cncr.22379" @default.
- W2077713044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17109447" @default.
- W2077713044 hasPublicationYear "2006" @default.
- W2077713044 type Work @default.
- W2077713044 sameAs 2077713044 @default.
- W2077713044 citedByCount "47" @default.
- W2077713044 countsByYear W20777130442012 @default.
- W2077713044 countsByYear W20777130442013 @default.
- W2077713044 countsByYear W20777130442014 @default.
- W2077713044 countsByYear W20777130442015 @default.
- W2077713044 countsByYear W20777130442016 @default.
- W2077713044 countsByYear W20777130442017 @default.
- W2077713044 countsByYear W20777130442018 @default.
- W2077713044 countsByYear W20777130442019 @default.
- W2077713044 countsByYear W20777130442020 @default.
- W2077713044 countsByYear W20777130442021 @default.
- W2077713044 countsByYear W20777130442022 @default.
- W2077713044 countsByYear W20777130442023 @default.
- W2077713044 crossrefType "journal-article" @default.
- W2077713044 hasAuthorship W2077713044A5044926112 @default.
- W2077713044 hasAuthorship W2077713044A5048720703 @default.
- W2077713044 hasAuthorship W2077713044A5056559714 @default.
- W2077713044 hasAuthorship W2077713044A5058495826 @default.
- W2077713044 hasAuthorship W2077713044A5073106835 @default.
- W2077713044 hasAuthorship W2077713044A5083011981 @default.
- W2077713044 hasAuthorship W2077713044A5089288192 @default.
- W2077713044 hasAuthorship W2077713044A5090055323 @default.
- W2077713044 hasAuthorship W2077713044A5090509109 @default.
- W2077713044 hasAuthorship W2077713044A5090814125 @default.
- W2077713044 hasBestOaLocation W20777130441 @default.
- W2077713044 hasConcept C126322002 @default.
- W2077713044 hasConcept C141071460 @default.
- W2077713044 hasConcept C143998085 @default.
- W2077713044 hasConcept C2776694085 @default.
- W2077713044 hasConcept C2777292972 @default.
- W2077713044 hasConcept C2777546739 @default.
- W2077713044 hasConcept C2778239845 @default.
- W2077713044 hasConcept C2780258809 @default.
- W2077713044 hasConcept C2780350996 @default.
- W2077713044 hasConcept C2781413609 @default.
- W2077713044 hasConcept C44249647 @default.
- W2077713044 hasConcept C71924100 @default.
- W2077713044 hasConcept C90924648 @default.
- W2077713044 hasConceptScore W2077713044C126322002 @default.
- W2077713044 hasConceptScore W2077713044C141071460 @default.
- W2077713044 hasConceptScore W2077713044C143998085 @default.
- W2077713044 hasConceptScore W2077713044C2776694085 @default.
- W2077713044 hasConceptScore W2077713044C2777292972 @default.
- W2077713044 hasConceptScore W2077713044C2777546739 @default.